MINAPHARM Pharmaceuticals (EGX:MIPH)

MINAPHARM Pharmaceuticals Revenue

MINAPHARM Pharmaceuticals had revenue of 2.28B EGP in the quarter ending June 30, 2026, with 31.48% growth. This brings the company's total for the last twelve months to 7.19B, up 4.71% year-over-year. In the year 2025, MINAPHARM Pharmaceuticals had annual revenue of 6.44B with 14.97% growth. That makes MINAPHARM Pharmaceuticals the 20,669th largest company in the world by revenue and 62nd in Egypt.

• Revenue (ttm): 7.19B
• Revenue Growth: +4.71%
• P/S Ratio: 1.22
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 8.75B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Bio Production 3.28B 51.0%
• Other Supplies 2.00B 31.1%
• Pharmaceutical Production 1.16B 18.0%

By Geography

Chart

• Egypt 3.85B 59.8%
• outside Egypt 2.59B 40.2%

Fiscal year ended Dec 31, 2025 See the full MINAPHARM Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.44B	838.51M	14.97%
Dec 31, 2024	5.60B	1.71B	43.87%
Dec 31, 2023	3.89B	271.51M	7.50%
Dec 31, 2022	3.62B	615.19M	20.47%
Dec 31, 2021	3.01B	644.34M	27.29%

Data Source: S&P Global Market Intelligence Last updated: Oct 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error